i2 Summit Program Overview

• Late-Breaking Clinical Trials each morning
• Late-Breaking Registries daily at noontime
• State-of-the-Art Lectures, followed by Live Cases focusing on:
•   Cedars-Sinai Medical Center, Cardiovascular Intervention Center (Los Angeles, California)
• Columbia University Medical Center (New York, New York)
• Hamburg University Cardiovascular Center (Hamburg, Germany)
• Helios Heart Center Siegburg (Siegburg, Germany)
• Mayo Clinic (Rochester, Minnesota)
• Oschner Heart and Vascular Institute (New Orleans, Louisiana)
• Presbyterian Dallas Hospital (Dallas, Texas)
• Saint Luke’s Mid America Heart Institute (Kansas City, Missouri)
• St. Paul’s Hospital (Vancouver, Canada
• St. Vincent Heart Center of Indiana (Indianapolis, Indiana)
• Controversies and Debates
• Multivessel diseas
• Acute M
• Stable angina, including silent ischemia
• High-risk anatom
• When to close atrial septal defects and patent foramen ovale

i2 Summit for the Cardiovascular Clinician

• Interactive cases, abstract presentations and expert-led discussions throughout the day
• Evaluation and management of valvular disease
• Pre- and post-PCI pharmacologic management
• Diagnosis and treatment options for renal stenosis, aortic aneurysm
• Diagnosis and treatment choices for carotid and peripheral arterial disease
• Appropriate use of drug-eluting stents: High-risk, complex patients

Endovascular Procedures

• Carotid artery disease
• Subclavian, vertebral, neurovascular/intracranial, acute stroke
• Ileofemoral disease
• Infrapopliteal disease
• Venous disease
• Renal and mesenteric disease
• Endovascular complication
• Thoracic and abdominal aortic diseases

Structural Heart Disease

• Closure of atrial septal defect, patent foramen ovale
• Coarctation of the aorta, patent ductus arteriosus, ventricular septal defect
• Aortic stenosis
• Mitral regurgitation, including paravalvular leak
• Left atrial appendix closure
• Mitral stenosis, aortic regurgitation
• Pulmonary and tricuspid valves
• Hemodynamics
• Acute CHF and chronic cardiomyopathy

Imaging Technology

• Intravascular ultrasound
• Optical coherence tomography and related technologies
• Computed tomography, magnetic resonance and co-registration
• Vulnerable plaque imaging and pathology
• Intracoronary physiology
• Noninvasive imaging for the interventionalist
• Imaging for structural heart disease
• Novel cath lab techniques — future concepts

Advanced Coronary Procedures

• Complex lesions: Bifurcations, left main disease, chronic total occlusions
• Drug-eluting stents, including saphenous vein grafts
• Acute coronary syndromes, acute MI
• Interventional cardiology complications
• Complex patients: Renal failure, diabetes, advanced age
• Interventional pharmacology
• Refractory ischemia, CHF, cell therapy, angiogenesis